PT-141 10mg Research Peptide
PT-141, also known as Bremelanotide, is a synthetic analog of α-MSH that activates melanocortin receptors (MC3R and MC4R) in the central nervous system. It is the only research peptide in its class FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in premenopausal women.
Purity
99.2% HPLC-tested purity with COA support.
Size
10mg Lyophilized Powder.
Storage
-20°C (Freezer)
Research use
For laboratory research use only. Not for human or veterinary use.
Mechanism of action
PT-141 binds MC4 receptors in the hypothalamus, triggering dopamine release in the medial preoptic area. Unlike PDE5 inhibitors which target blood flow, PT-141 acts on the central pathways that govern libido and arousal — making it of interest for research into neurologically-mediated sexual response.
Research applications
- Sexual response and libido research
- Melanocortin receptor pharmacology
- Central nervous system arousal studies
- Hypoactive sexual desire disorder research
- Erectile function & arousal research
Frequently asked questions
What is PT-141 used for in research?
PT-141 (Bremelanotide) is researched for its effects on sexual desire and arousal via central melanocortin receptor activation, in contrast to vascular-targeted compounds.
How is PT-141 different from Viagra?
PT-141 acts on the central nervous system (MC4R in the hypothalamus). Viagra/Cialis are PDE5 inhibitors that work on vascular blood flow. They target different stages of sexual response.
Is your PT-141 third-party tested?
Yes. Every vial ships with HPLC and Mass Spec verification at ≥99.2% purity and an itemized Certificate of Analysis.
Browse research peptides for sale · View lab reports · Read peptide FAQ